Real-time enrollment status for this her2-positive breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:46 AM UTC
| NCT Number | NCT05868226 |
| Recruiting Status | Recruiting |
| Condition | HER2-positive Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 124 participants |
| Active Locations | 7 sites in the US |
| Sponsor | QuantumLeap Healthcare Collaborative |
| Last Updated on CT.gov | April 4, 2025 (Apr 4, 2025) |
As of July 13, 2026: Clinical trial NCT05868226 is currently recruiting participants. This clinical trial study for her2-positive breast cancer is actively seeking new participants at 7 locations across the United States. The study is sponsored by QuantumLeap Healthcare Collaborative. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05868226 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05868226 was last updated Apr 4, 2025 (April 4, 2025). HelloStudys verifies this status automatically.